Showing results (1211-1220 of 1,226) with videos related to

Sort By:
Pageof 123
Blood|January 29, 2021
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational studyNiloufer Khan, Sarah Lindner, Antonio L C Gomes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2024
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced DyskinesiaYuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, et al.
Science Translational Medicine|May 25, 2022
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCTHana Andrlová, Oriana Miltiadous, Anastasia I Kousa, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Sugar-rich foods exacerbate antibiotic-induced microbiome injuryAnqi Dai, Peter A Adintori, Tyler Funnell, et al.
Blood|May 21, 2020
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHDKate A Markey, Jonas Schluter, Antonio L C Gomes, et al.
Molecules (Basel, Switzerland)|January 8, 2020
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6Jean Jacques Vanden Eynde, Arduino A Mangoni, Jarkko Rautio, et al.
Molecules (Basel, Switzerland)|July 2, 2020
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-7Michael Gütschow, Jean Jacques Vanden Eynde, Josef Jampilek, et al.
Nature Medicine|March 15, 2022
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Anqi Dai, Guido Ghilardi, et al.
Lancet Regional Health. Americas|March 13, 2023
Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX - REVOLUTIOn trialIsrael S Maia, Aline Marcadenti, Viviane C Veiga, et al.
Non-Coding RNA|April 3, 2019
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129Clarissa Pedrosa da C Gomes, Bence Ágg, Andrejaana Andova, et al.
Pageof 123